TMCnet News
Research and Markets: Global Herpes Simplex Infections Therapeutics Pipeline Review, H2 2015Research and Markets (http://www.researchandmarkets.com/research/d34n87/herpes_simplex) has announced the addition of the "Herpes Simplex Infections - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Simplex Infections and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gan competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/d34n87/herpes_simplex
View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005391/en/ |